[Erythroderma caused by carbamazepine. Diagnosis with skin patch].
We present two cases of cutaneous erythroderma induced by carbamazepine therapy, both cases with just cutaneous affection and only one suspicious drug. A cutaneous patch study, with standard battery from the Spanish Contact Dermatitis Research Group, vaseline with carbamazepine at 10% and lectures at 48 and 96 hours, was conducted. The result was positive for carbamazepine and negative for all other patches in both cases. All controls were negative. This is a very simple test, easy to perform, specific and with low side effects, allowing the diagnosis of this pathology.
Blasco Sarramían
A
A
Servicio de Alergología, Complejo Hospitalario San Millán-San Pedro, Logroño, La Rioja.
Pinilla Moraza
J
J
Atares Pueyo
M B
MB
Lobera Labairu
T
T
Izquier-Do Cuartero
M A
MA
San Román Lazcano
F J
FJ
D000328:Adult; D002220:Carbamazepine / Q000009:adverse effects*; D003873:Dermatitis, Exfoliative / Q000139:chemically induced* / Q000175:diagnosis*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010328:Patch Tests
D002220:Carbamazepine
Eritrodermia por carbamacepina. Su diagnóstico mediante parche cutáneo.